HPA and its sponsors NSF International and TSI Group concluded its 2017 edition of its annual “China International Nutrition and Health Industry Summit” on June 19, 2017 in Shanghai.

The association welcomed 110 attendees to the all day event, which was position the day before HNC expo also in Shanghai.

IMG_7051 copy

The event featured 10 expert speakers covering Import / Export Status of Dietary Supplements, Latest Regulations for Finished Dietary Supplements and Nutritional ingredients, Foods for Special Medical Purposes Insights, Cross Border E-Commerce, China’s New Consumers and their Buying Habits, Professional Consumer Issues, Probiotic Trends, Omega-3 trends and a State of the Industry Panel Discussion led by Gary Scattergood Editor in Chief from NutraIngredients-Asia. A special thanks goes out to the summit speakers:

Mr. Zhang Zhongpeng Deputy Director China Chamber of Commerce for Import/Export of Medicine & Health Products

Dr. Wendell Wei Director China Gate Consulting

Dr. Shi Hanping Chief Member of TSI Group Scientific Advisory Board

Daniel Yiu International Director Ali-Health (Alibaba)

Gautam Seth Vice President Innovation Practices Nielsen Group

David Ettinger Attorney/Partner Keller & Heckman

David Trosin Business Development Director NSF International

George Paraskevakos Executive Director Global International Probiotics Association

Adam Ismail Executive Director Global Organization for EPA & DHA Omega-3s

Dr. Petter-Arnt Hals Director of R&D Aker BioMarine

IMG_7090 copy

The Summit offered the attendees many opportunities to learn, share and network with their industry colleagues.

The association’s next event will be the “China International Sports Nutrition Industry Summit” taking place on September 6, 2017 in Shanghai the day before FIBO China, which is China’s premiere Sports and Fitness expo.IMG_7067 copy

We look forward to seeing you in Shanghai. If you are interested in learning more about HPA’s events in China, please contact us at summit@uschinahpa.org (Source: HPA China)

Comments are closed.